Connect Biopharma Holdings Limited Deductible Temporary Differences For Which No Deferred Tax Asset Is Recognised
Connect Biopharma Holdings Limited (CNTB) had Deductible Temporary Differences For Which No Deferred Tax Asset Is Recognised of $366.80 million as of 2023-12-31, per its 20-F filed 2024-04-16.
Discontinued › Notes › Income Taxes
ifrs-full:DeductibleTemporaryDifferencesForWhichNoDeferredTaxAssetIsRecognised · last filed 2024-04-16
- 2022-12-31: Deductible Temporary Differences For Which No Deferred Tax Asset Is Recognised 2.20B CNY.
- 2021-12-31: Deductible Temporary Differences For Which No Deferred Tax Asset Is Recognised 1.33B CNY.
- 2020-12-31: Deductible Temporary Differences For Which No Deferred Tax Asset Is Recognised 582.00M CNY.
- 2019-12-31: Deductible Temporary Differences For Which No Deferred Tax Asset Is Recognised 284.00M CNY.
CNY
| Period end | Deductible Temporary Differences For Which No Deferred Tax Asset Is Recognised |
|---|---|
| 2022-12-31 | 2.20B CNY 20-F · filed 2023-04-11 |
| 2021-12-31 | 1.33B CNY 20-F · filed 2023-04-11 |
| 2020-12-31 | 582.00M CNY 20-F · filed 2023-04-11 |
| 2019-12-31 | 284.00M CNY 20-F · filed 2022-03-31 |
USD
| Period end | Deductible Temporary Differences For Which No Deferred Tax Asset Is Recognised |
|---|---|
| 2023-12-31 | $366.80M 20-F · filed 2024-04-16 |
| 2022-12-31 | $316.40M 20-F · filed 2024-04-16 |
| 2021-12-31 | $208.10M 20-F · filed 2024-04-16 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Yarrow Bioscience, Inc. (YARW) | United States | $0.070B | |
| PLIANT THERAPEUTICS, INC. (PLRX) | United States | $0.071B | -0.76 |
| TENAX THERAPEUTICS, INC. (TENX) | United States | $0.071B | -7.17 |
| PMV Pharmaceuticals, Inc. (PMVP) | United States | $0.071B | -0.95 |
| Lunai Bioworks Inc. (LNAI) | United States | $0.072B | -0.11 |
| XBiotech Inc. (XBIT) | United States | $0.066B | -1.56 |
| Spero Therapeutics, Inc. (SPRO) | United States | $0.073B | 17.41 |
| Cingulate Inc. (CING) | United States | $0.073B | -2.64 |
| HYPERION DEFI, INC. (HYPD) | United States | $0.065B | |
| Aldeyra Therapeutics, Inc. (ALDX) | United States | $0.074B | -5.57 |